The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...
Oracle stock still looks like a "Buy" with an intrinsic value of $220 and AI-driven cloud growth. Here's what investors need ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 21, 2026 / For decades, luxury operated on an unspoken agreement: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results